Hot This Week in Indian Stock Market

Stock Recommendations

Here are daily stock recommendations for intraday mock trading of NSE/BSE cash, futures, and options from Tower Talk.

Tower Talk provides recommendations every weekend for the week ahead. Here you can find their recommendations and we track their success rate too. So that you understand the risks involved in following them.

7 to 11 August 2017

Stock and News Call CMP TGT Success/Fail
Tata Elexi reported much improved results for Q1. The company declared a dividend of Rs. 16/- per share and also bonus shares in the ratio of 1:1. The share is rumoured to cross the magical price of Rs. 2000/- in a short time.

Buy 1696 2000  
Maruti Suzuki reported a net profit of 1556.4 Cr. for Q1. This company has huge expansion plans on hand and even at current prices, it does merit a buy.

Buy 7775 8552.5  
Shriram Transport Finance net profits rose by around 20% to 448.68 Cr. The share is still a good buy considering rising volumes of Truck sales and growth of the logistics industry.

Buy 991 1090.1  
Sonata Software received distinction of being named Microsoft ISV Development Centre. This collaboration will bring huge opportunities to its fold. This cash rich company must be added. BUY.

Buy 160 176  
SBI has reduced interest rates on savings accounts deposits below one Cr. from 4% to 3.5%. This will decrease cost of funds and increase profitability. Positive for SBI.

Buy 305.8 336.38  
Sona Koyo (auto ancillary giant making steering wheels primarily for Maruti and other four wheelers) is faring extremely well. Buy for a year.

Buy 114 125.4  
Tech Mahindra beat market expectations by declaring a big jump in profits. The company expects the margins to be maintained during the rest of the year. Accumulate.

Buy 409 449.9  
Birla Corporation is setting up a Greenfield cement plant in Mukutban, Maharshtra (a cement starved state) at a cost of around 2400 Cr. After this 4 million tonnes addition, the total capacity will increase to 19.5 million tonnes. Big positive.

Buy 960 1056  
Shakti Pumps shares being acquired by foreign funds. They expect the company to prices to take a big leap. A good long term bet.

Buy 505 555.5  
BEL Q1 profits rose 247.24% to 125.32Cr., on a 99% increase in sales, primarily on back of better defence orders. The pace is likely to continue for the rest of the year.


Buy 179.5 197.45  
Escorts Ltd has reported a 34% rise in Agri machinery for Q1. The tractor division and the motor cycle divisions are performing well. Profitability may take a 50% jump and so will the prices.

Buy 670.25 737.275  
India Bull Real Estate posted double profits for Q1. The affordable housing sector is in a bull cycle. A prudent investment may give decent returns.

Buy 248.1 272.91  
South India Bank Q1 net profit climbed 18% at 110.52 Cr. A climb in CASA ratio and declining NPAs are indications of better times to come.

Buy 29.3 32.23  
GSFC, a fertilizer major and prominent manufacturer of Caprolactum, a basic input to make tyres, has increased prices. A good buy at current prices.

Buy 136 149.6  
A lot of action is being witnessed in Oil Marketing Companies. It would be prudent to add IOC the results of which were fairly good.

Buy 418 459.8  
A distinct rise in volumes of Tube Investments of India is indicating that there is some news in the offing. This Murguppa group company is worth accumulating.

Buy 755.75 831.325  
ACC is showing witnessing a slow and steady rise in volumes and price too. And the merger with Ambuja will also aid rise in valuations. A good buy even now.

Buy 1818.45 2000.295  
Power Grid reported an 18% jump in revenues (7390 Cr) for Q12017, and a net profit of 2052 Cr. With huge project hand, this is one of the best long term investment idea.

Buy 224 246.4  
REC and PFC are both going to announce their Q1 results this week. There is practically no place to go down. Any good news on pending NPA issues may fuel a rally. BUY.

Buy 174.25 191.675  
REC and PFC are both going to announce their Q1 results this week. There is practically no place to go down. Any good news on pending NPA issues may fuel a rally. BUY.

Buy 128.15 140.965  
In spite of minor observations from USFDA, Biocon is still a good buy, especially after the recent correction. Buy for a short term target of Rs. 400/-.

Buy 356.65 400  


The information on this web-page is NOT any recommendation on buy and sell of stocks and/or derivatives. The information on this web-page is just for education and entertainment purpose. We do not claim that the information on this web-page is accurate. Sharesume or anyone from our team is not responsible for the inaccuracy of the information. Sharesume or anyone from our team is not responsible for any profits or loss that you make.